LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)
Data as of , from SEC Form 4 filings.
See up to 3 months of LFCR. The 7-day demo opens the 1M and 3M ranges and puts LFCR on your watchlist.
Start 7-day demoLatest LFCR insider trades
Aron R. EnglishOpen-market sale$649K- Aron R. EnglishOpen-market sale$7.41M
About LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
- CHASKA, MN
- 382
- 1996
- XNAS
LFCR Form 4 activity by transaction type, last 90 days
No Form 4 activity for LFCR in the last 90 days.
LFCR insider transactions (Form 4)
834 Form 4 filings on record, the earliest from Oct 7, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Ryan David Lake - Officer | Grant or award | Common Stock | 19,720 | $0.00 | - | |
| Ryan David Lake - Officer | Tax withholding / forfeiture | Common Stock | 5,653 | $7.15 | $40K | |
| Ryan David Lake - Officer | Option exercise | Common Stock | 75,000 | - | - | |
| Ryan David Lake - Officer | Tax withholding / forfeiture | Common Stock | 34,138 | $5.09 | $174K | |
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP I - 10% Owner | Open-market purchase | Common Stock, $0.001 par value per share | 122,930 | $4.10 | $504K | |
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP I - 10% Owner | Open-market purchase | Common Stock, $0.001 par value per share | 169,753 | $4.10 | $696K | |
| Christopher S. Kiper - Director | Open-market purchase | Common Stock | 1,311,312 | $4.10 | $5.38M | |
| Christopher S. Kiper - Director | Open-market purchase | Common Stock | 152,102 | $4.10 | $624K |
LFCR insider trading FAQ
What is the latest insider trade for LFCR?
LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-08. The full record for LFCR runs to 34 Form 4 filings, the earliest from 2024-10-07. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying LFCR stock?
No insider purchases of LFCR were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling LFCR stock?
No insider sales of LFCR were filed in the last 90 days. 10 sales are on record for this company.
Where can I see LFCR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects LFCR Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Christopher S. Kiper view on EDGAR
- - Nelson Obus view on EDGAR
- - Jason Aryeh view on EDGAR
- - Joshua Schechter view on EDGAR
- - Matthew E. Korenberg view on EDGAR
- - Humberto Calheiros Antunes view on EDGAR
- - Paul Harold Johnson view on EDGAR
- - Lovas Katrina Houde view on EDGAR
- - Paul Josephs view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where LFCR's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow LFCR with a 7-day demo
- LFCR on your watchlist
- Every LFCR Form 4 filing on record
- Up to 3 months of LFCR price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
